Cancer Research UK’s spin-out, GammaDelta Therapeutics, has been given approval to trial its unique T-cell therapy in the US.
The first participants have taken part in a new research trial that aims to save lives by detecting lung cancer at an earlier stage when it is more treatable.
People who have previously been treated for a type of bowel cancer that has spread to other parts of their body will now have another treatment option in England.
Around 10,600 fewer breast cancer patients have started treatment in the last year in England, as experts fear hard-won progress could slow.
Hormone treatment enzalutamide will now be offered as an alternative combined treatment option for some adults with prostate cancer on the NHS in England.
The new findings shed light on how cancer cells found in different parts of a tumour behave differently.
Dr Alison Berner and team asked 140 trans men and non-binary people to share their past experiences and attitudes towards cervical screening.
Cancer Research UK’s spinout, Achilles Therapeutics plc (‘Achilles’), has raised $175.5 million through the closing of its initial public offering (IPO).